Cargando…
Novel Biomarkers to Distinguish between Type 3c and Type 2 Diabetes Mellitus by Untargeted Metabolomics
Pancreatogenic diabetes mellitus (T3cDM) is a highly frequent complication of pancreatic disease, especially chronic pancreatitis, and it is often misdiagnosed as type 2 diabetes mellitus (T2DM). A correct diagnosis allows the appropriate treatment of these patients, improving their quality of life,...
Autores principales: | Jimenez-Luna, Cristina, Martin-Blazquez, Ariadna, Dieguez-Castillo, Carmelo, Diaz, Caridad, Martin-Ruiz, Jose Luis, Genilloud, Olga, Vicente, Francisca, del Palacio, Jose Perez, Prados, Jose, Caba, Octavio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690399/ https://www.ncbi.nlm.nih.gov/pubmed/33105675 http://dx.doi.org/10.3390/metabo10110423 |
Ejemplares similares
-
Untargeted Metabolomics for the Diagnosis of Exocrine Pancreatic Insufficiency in Chronic Pancreatitis
por: Díaz, Caridad, et al.
Publicado: (2021) -
Discovery of Pancreatic Adenocarcinoma Biomarkers by Untargeted Metabolomics
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2020) -
Untargeted LC-HRMS-based metabolomics to identify novel biomarkers of metastatic colorectal cancer
por: Martín-Blázquez, Ariadna, et al.
Publicado: (2019) -
State of the Art in Exocrine Pancreatic Insufficiency
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020) -
Role of Exocrine and Endocrine Insufficiency in the Management of Patients with Chronic Pancreatitis
por: Diéguez-Castillo, Carmelo, et al.
Publicado: (2020)